APA (7th ed.) Citation

Steinhardt, M. J., Cejka, V., Chen, M., Bäuerlein, S., Schäfer, J., Adrah, A., . . . Lund University, F. o. E. (2024). Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis—A Clinical Feasibility Study. Journal of Clinical Medicine, 13(1), . https://doi.org/10.3390/jcm13010283

Chicago Style (17th ed.) Citation

Steinhardt, Maximilian J., et al. "Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis—A Clinical Feasibility Study." Journal of Clinical Medicine 13, no. 1 (2024). https://doi.org/10.3390/jcm13010283.

MLA (9th ed.) Citation

Steinhardt, Maximilian J., et al. "Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis—A Clinical Feasibility Study." Journal of Clinical Medicine, vol. 13, no. 1, 2024, https://doi.org/10.3390/jcm13010283.